Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for iBio (IBIO) over the last 10 years, with Q4 2025 value amounting to $99.1 million.

  • iBio's Shares Outstanding (Diluted Average) rose 98555.63% to $99.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $99.1 million, marking a year-over-year increase of 98555.63%. This contributed to the annual value of $10.5 million for FY2025, which is 17405.38% up from last year.
  • Per iBio's latest filing, its Shares Outstanding (Diluted Average) stood at $99.1 million for Q4 2025, which was up 98555.63% from $53.0 million recorded in Q3 2025.
  • In the past 5 years, iBio's Shares Outstanding (Diluted Average) ranged from a high of $215.5 million in Q1 2021 and a low of $490000.0 during Q4 2022
  • In the last 5 years, iBio's Shares Outstanding (Diluted Average) had a median value of $8.7 million in 2021 and averaged $23.5 million.
  • In the last 5 years, iBio's Shares Outstanding (Diluted Average) tumbled by 9595.48% in 2022 and then skyrocketed by 98555.63% in 2025.
  • iBio's Shares Outstanding (Diluted Average) (Quarter) stood at $8.7 million in 2021, then plummeted by 94.38% to $490000.0 in 2022, then skyrocketed by 278.78% to $1.9 million in 2023, then surged by 392.03% to $9.1 million in 2024, then surged by 985.56% to $99.1 million in 2025.
  • Its last three reported values are $99.1 million in Q4 2025, $53.0 million for Q3 2025, and $10.5 million during Q2 2025.